findmyKOL
Clinical trialNCT06567743RecruitingPhase 2Interventional

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

SponsorCG Oncology, Inc.Enrollment325High-Risk Non-Muscle-Invasive Bladder Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

65 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic Arizona

    Phoenix, Arizona, United States

    Mark Tyson, MD
    Recruiting
  • Arizona Urology Specialty

    Tucson, Arizona, United States

    Withdrawn
  • Arkansas Urology

    Little Rock, Arkansas, United States

    Jon Henderson, MD
    Recruiting
  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, United States

    Ahmet Aydin, MD
    Recruiting
  • Michael G Oefelein, Md Clinical Trials

    Bakersfield, California, United States

    Michael G Oefelein, MD
    Recruiting
  • Genesis Research (greater Los Angeles)

    Los Alamitos, California, United States

    Sepehr Nowfar, MD
    Recruiting
  • Advanced Urology

    Los Angeles, California, United States

    Withdrawn
  • Urology Center of Southern California

    Murrieta, California, United States

    Madhumitha Reddy, MD
    Recruiting
  • University of California, Irvine

    Orange, California, United States

    Edward Uchio, MD
    Recruiting
  • Om Research

    San Diego, California, United States

    Paul Dato, MD
    Recruiting
  • University of Southern California

    San Diego, California, United States

    Siamek Daneshmand, MD
    Recruiting
  • Genesis Research (greater Los Angeles)

    Torrance, California, United States

    Timothy Lesser, MD
    Recruiting
  • Colorado Urology

    Lakewood, Colorado, United States

    David Cahn, MD
    Recruiting
  • Urology Associates, Lone Tree

    Lone Tree, Colorado, United States

    Daniel Mazur, MD
    Recruiting
  • University of Florida

    Gainesville, Florida, United States

    Padaric O'Malley, MD
    Recruiting
  • Mayo Clinic Florida

    Jacksonville, Florida, United States

    Andrew Zganjar, MD
    Recruiting
  • Advanced Urology Institute (solaris)

    Largo, Florida, United States

    Matthew Truesdale, MD
    Recruiting
  • Advanced Urology Institute

    Oxford, Florida, United States

    Edward King, MD
    Recruiting
  • Advanced Urology Institute - Tallahassee (solaris)

    Tallahassee, Florida, United States

    Withdrawn
  • Emory University

    Atlanta, Georgia, United States

    Shreyas Joshi, MD
    Recruiting
  • Associated Urological Specialists

    Chicago Ridge, Illinois, United States

    Aaron Berger, MD
    Recruiting
  • Uropartners

    Glenview, Illinois, United States

    Jeffrey Pearl, MD
    Recruiting
  • Urology of Indiana - Carmel

    Carmel, Indiana, United States

    Chad Reichard, MD
    Recruiting
  • Urology of Indiana, Llc (us Urology Partners)

    Greenwood, Indiana, United States

    Eugene Cone, MD
    Recruiting
  • First Urology, Psc

    Jeffersonville, Indiana, United States

    Ryan Malone, MD
    Recruiting
  • Urologic Specialists of Northwest Indiana (solaris)

    Merrillville, Indiana, United States

    Manoj Rao, MD
    Recruiting
  • Urology Center of Iowa Research

    Clive, Iowa, United States

    Brian Gallagher, MD
    Recruiting
  • Wichita Urology Group

    Wichita, Kansas, United States

    Philippe Nabbout, MD
    Recruiting
  • Southern Urology (urology America)

    Lafayette, Louisiana, United States

    Jason Bourque, MD
    Recruiting
  • Ochsner Medical Center

    New Orleans, Louisiana, United States

    Kyle Rose, MD
    Recruiting
  • Anne Arundel Urology

    Annapolis, Maryland, United States

    Mara Holton, MD
    Recruiting
  • Chesapeake Urology Research Associates

    Hanover, Maryland, United States

    Rian Dickstein, MD
    Recruiting
  • Comprehensive Urology

    Royal Oak, Michigan, United States

    Adam Gadzinski, MD
    Recruiting
  • Michigan Institute of Urology (solaris)

    Troy, Michigan, United States

    Jason Hafron, MD
    Recruiting
  • Mayo Clinic Rochester

    Rochester, Minnesota, United States

    Paras Shah, MD
    Recruiting
  • Minnesota Urology

    Woodbury, Minnesota, United States

    Aaron Milbank, MD
    Recruiting
  • Specialty Clinical Research of St. Louis

    St Louis, Missouri, United States

    Gregory Auffenberg, MD
    Recruiting
  • Adult and Adolescent Urology

    Omaha, Nebraska, United States

    Andrew Trainer, MD
    Recruiting
  • Integrated Medical Professionals, Pllc (solaris)

    New York, New York, United States

    Jed Kaminetsky, MD
    Recruiting
  • University of Rochester

    Rochester, New York, United States

    William Tabayoyong, MD
    Recruiting
25 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cretostimogene Grenadenorepvec
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Sept 2024
Primary completion
31 Mar 2027
Completion
30 Dec 2027
Last update posted
8 Apr 2026
Registered enrollment
325
Registry id
NCT06567743

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.